Alpha Cognition Inc.
ACOG- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001655923
In the last 90 days, Alpha Cognition Inc. insiders filed 6 open-market purchases and 0 sales; 26 institutions reported holding it in 13F filings for Q2 2026, worth $75.7M in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Alpha Cognition Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 26 | 28 | +2 |
| Shares | 5.72M | 5.64M | −75.9K (−1.3%) |
| Value | $53.4M | $36.7M | −$16.6M (−31.1%) |
New holders (7)
Institutions that held Alpha Cognition Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Opaleye Management Inc. | 115,142 | $749.6K | 0.11% |
| Connective Capital Management, LLC | 47,931 | $312.0K | 0.29% |
| Two Sigma Investments, LP | 22,728 | $148.0K | 0.00% |
| Zullo Investment Group, Inc. | 19,500 | $126.9K | 0.05% |
| Quadrature Capital Ltd | 13,642 | $88.8K | 0.00% |
| Tower Research Capital LLC (TRC) | 1,648 | $10.7K | 0.00% |
| Jones Financial Companies LLLP | 200 | $1.42K | 0.00% |
Sold out (5)
Institutions that held Alpha Cognition Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Bleichroeder LP | 138,919 | $1.30M |
| Manatuck Hill Partners, LLC | 117,000 | $1.09M |
| Wexford Capital LP | 16,666 | $155.5K |
| Massar Capital Management, LP | 12,433 | $116.0K |
| BlackRock, Inc. | 5,443 | $50.8K |